VeinViewer Vein Scanner Provides Innovative Solution to Vascular Access Challenges
MEMPHIS, Tenn. - (May 13, 2015) - Christie Medical Holdings, the global leader in vein imaging solutions, will exhibit its award winning VeinViewer® technology at this year’s Convention & Industrial Exhibition of the Infusion Nurses Society. The annual conference is being held at the Kentucky International Convention Center in Louisville, Kentucky this year. Exhibit days are May 18-20. VeinViewer by Christie will be on display in booth 436.
VeinViewer is a vein visualization device that uses harmless, near-infrared light to project a real-time, HD image of a patient’s veins directly on the surface of their skin. VeinViewer is the only direct projection vein finder on the market capable of providing a clinician information Pre-, During and Post vascular access.
In a position paper discussing patient safety the Infusion Nurses Society emphasized the importance of understanding preinsertion, insertion and postinsertion practices to ensure patient safety. "The INS position paper aligns with the benefits of VeinViewer technology," says Erin Shelton, VeinViewer product manager. "The technology can help a healthcare provider find the optimal site on a patient to start a peripheral IV, and because it has real-time imaging, VeinViewer is able to provide information after the IV is placed."
The INS position paper also recommends "incorporating vein visualization technology as a routine strategy for patients with difficult or poor venous access," stating that "visualization technology can improve success rates, decrease unsuccessful insertion attempts, and improve patient satisfaction."
All three of the supporting evidence papers cited in the panel’s research regarding recommendations for vein visualization technology were studies conducted using VeinViewer by Christie.
VeinViewer technology is clinically proven to increase first-stick success rates by up to 100%, increase patient satisfaction 100% and decrease the number of PICC lines (peripherally inserted central catheters) placed because peripheral IV access could not be achieved.
An educational poster scheduled for presentation at INS 2015 examines the use of near-infrared light technology as a means to reduce PICC line placement. It shows a significant reduction in the number of PICC lines placed after implementation of near-infrared light technology as a means to increase successful peripheral IV placement.
To learn more about Christie vein finding devices: VeinViewer Vision2, VeinViewer VisionXTND and VeinViewer Flex, please visit www.christiemed.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.
Follow us on Twitter @christiemed
Christie® is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.
DLP® is a registered trademark of Texas Instruments.